You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com
HCV - Drug Abuse / Injection Drug Use
Little Change in Hepatitis C Risk among Injection Drug Users 2-11-2011 Hepatitis C Virus Can Survive in Syringes Up to 2 Months under Favorable Conditions 2-23-2010 Advocates Urge Consideration of Hepatitis C Treatment for Active Injection Drug Users 8-14-2009 HCV Reinfection and Superinfection Are Common among Injection Drug Users 3/24/09
Further Evidence Shows that Hepatitis C Virus (HCV) Can Be Transmitted through Snorting Drugs 9/19/08 Active Injection Drug Use Does Not Impair Sustained Response to Hepatitis C Treatment in Adherent Patients 7/22/08 Prevalence of Hepatitis C Virus Infection among Injection Drug Users in the U.S. 7/11/08 FDA Revises Process for Responding to Drug Approval Applications from Pharmaceutical Companies 7/11/08 Active and Recovering Injection Drug Users Can Benefit from Hepatitis C Treatment if They Maintain Good Adherence 6/10/08 Marijuana Use Sparks Liver Transplant Controversy 6/06/08 Alcohol, Tobacco, and Cannabis All May Promote Liver Disease Progression in People with Chronic Hepatitis C 3/28/08 Methamphetamine Promotes Hepatitis C Virus Replication in Human Liver Cells 3/07/08